LCM
BMY icon

Lucas Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Lucas Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.67M Sell
26,975
-846
-3% -$52K 1.95% 18
2020
Q3 		$1.68M Sell
27,821
-1,722
-6% -$104K 2.25% 17
2020
Q2 		$1.74M Sell
29,543
-1,670
-5% -$99.9K 2.38% 15
2020
Q1 		$1.74M Buy
31,213
+995
+3% +$60.8K 2.63% 14
2019
Q4 		$1.94M Buy
30,218
+3,080
+11% +$176K 2.3% 17
2019
Q3 		$1.38M Sell
27,138
-1,910
-7% -$89.8K 1.75% 24
2019
Q2 		$1.32M Sell
29,048
-6,070
-17% -$283K 1.56% 28
2019
Q1 		$1.68M Sell
35,118
-4,920
-12% -$245K 1.98% 21
2018
Q4 		$2.08M Sell
40,038
-2,505
-6% -$135K 2.74% 12
2018
Q3 		$2.64M Sell
42,543
-20,166
-32% -$1.2M 3.19% 11
2018
Q2 		$3.47M Buy
62,709
+286
+0.5% +$15.4K 3.28% 5
2018
Q1 		$3.78M Sell
62,423
-1,298
-2% -$83.5K 3.66% 3
2017
Q4 		$3.9M Sell
63,721
-3,665
-5% -$229K 3.38% 4
2017
Q3 		$4.29M Sell
67,386
-2,185
-3% -$128K 3.85% 4
2017
Q2 		$3.88M Buy
69,571
+12,203
+21% +$664K 2.81% 5
2017
Q1 		$3.12M Sell
57,368
-5,010
-8% -$275K 2.31% 10
2016
Q4 		$3.65M Buy
62,378
+13,255
+27% +$725K 2.63% 10
2016
Q3 		$2.65M Buy
49,123
+2,485
+5% +$160K 2.03% 15
2016
Q2 		$3.43M Sell
46,638
-1,085
-2% -$76.7K 2.43% 10
2016
Q1 		$3.05M Buy
47,723
+1,195
+3% +$75.4K 2.23% 11
2015
Q4 		$3.2M Sell
46,528
-4,370
-9% -$289K 2.06% 13
2015
Q3 		$3.01M Hold
50,898
– – 1.75% 14
2015
Q2 		$3.39M Sell
50,898
-350
-0.7% -$23.1K 1.51% 19
2015
Q1 		$3.31M Sell
51,248
-5,375
-9% -$336K 1.33% 23
2014
Q4 		$3.34M Sell
56,623
-7,185
-11% -$405K 1.24% 26
2014
Q3 		$3.27M Sell
63,808
-870
-1% -$43.5K 1% 38
2014
Q2 		$3.14M Buy
64,678
+3,465
+6% +$171K 1% 39
2014
Q1 		$3.18M Sell
61,213
-2,025
-3% -$108K 1.01% 36
2013
Q4 		$3.36M Sell
63,238
-5,890
-9% -$300K 1.12% 35
2013
Q3 		$3.2M Buy
69,128
+6,088
+10% +$267K 1.09% 33
2013
Q2 		$2.82M Buy
+63,040
New +$2.74M 0.81% 34

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lucas Capital Management's BMY Position: Q4 2020 in Review

Lucas Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 3% in Q4 2020, selling an estimated $52K and leaving 26,975 shares worth $1.67M. The position accounts for 1.95% of the portfolio, ranked #18.

Lucas Capital Management first reported a position in BMY in Q2 2013 and has held it in 31 quarters since. The position peaked at $4.29M in Q3 2017. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Lucas Capital Management held 26,975 shares of Bristol-Myers Squibb worth $1.67M as of Q4 2020.
  • Lucas Capital Management sold 846 Bristol-Myers Squibb shares in Q4 2020, an estimated $52K.
  • Bristol-Myers Squibb made up 1.95% of Lucas Capital Management's portfolio in Q4 2020, its #18 holding.
  • Lucas Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 31 quarters since.
  • Lucas Capital Management's Bristol-Myers Squibb position peaked at $4.29M in Q3 2017.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Lucas Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.